Antimicrobial drug discovery: emerging strategies (Record no. 315559)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03215nam a22008174u 4500 |
| 001 - CONTROL NUMBER | |
| control field | 10.1079/9781845939434.0000 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | CABI |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20231004110338.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr nn 008mam|a |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 120831t2012||||xxu fs| |0|| 0|eng|| |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781780640310 |
| Qualifying information | electronic |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1079/9781845939434.0000 |
| Source of number or code | doi |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | eng |
| 245 00 - TITLE STATEMENT | |
| Title | Antimicrobial drug discovery: emerging strategies |
| Medium | [electronic resource] |
| Statement of responsibility, etc | Edited by A. Tegos, E. Mylonakis. |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 1 |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Place of publication, distribution, etc | Wallingford UK |
| Name of publisher, distributor, etc | CABI |
| Date of publication, distribution, etc | 2012 |
| 264 #1 - | |
| -- | Wallingford UK |
| -- | CABI |
| -- | 2012 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 357pp.; |
| 336 ## - | |
| -- | text |
| -- | txt |
| -- | rdacontent |
| 337 ## - | |
| -- | computer |
| -- | c |
| -- | rdamedia |
| 338 ## - | |
| -- | online resource |
| -- | cr |
| -- | rdacarrier |
| 347 ## - | |
| -- | text file |
| -- | rdaft |
| 347 ## - | |
| -- | |
| 490 1# - SERIES STATEMENT | |
| Series statement | Advances in Molecular and Cellular Microbiology |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc | Drug resistance is increasing among a variety of human pathogenic microorganisms such as Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumaniii, Pseudomonas aeruginosa and Enterobacter spp. (currently dubbed the 'ESKAPE' pathogens), and has emerged as one of the most important clinical challenges of this century. Increased general awareness and fear of these pathogens means there is a growing demand for research to tackle the threat of multidrug resistance. Documenting the latest research in the field, this book discusses current and promising activities to discover new antimicrobials in five key areas: molecular genetics and systems microbiology; synthetic, computational chemistry and chemoinformatics; High Throughput Screening (HTS); non-vertebrate model hosts; and light- and nano-based technologies. |
| 653 00 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | carbon nanotubes |
| 653 00 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | eukaryotes |
| 653 00 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | drug development |
| 653 00 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | biofilms |
| 653 00 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | antibiotics |
| 653 00 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | bacterium |
| 653 00 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | bacterioses |
| 653 00 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | lipopolysaccharides |
| 653 00 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | quorum sensing |
| 653 00 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | fungistats |
| 653 00 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | infections |
| 653 00 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | prokaryotes |
| 653 00 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | Bacteria |
| 653 00 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | nanotubes |
| 653 00 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | drug targets |
| 653 00 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | drug resistance |
| 653 00 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | phototherapy |
| 653 00 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | antifungal agents |
| 653 00 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | peptide antibiotics |
| 653 00 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | bacterial diseases |
| 653 00 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | animal models |
| 653 00 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | photochemotherapy |
| 653 00 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | efflux pumps |
| 653 00 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | fungus |
| 653 00 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | nanotechnology |
| 653 00 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | disease models |
| 653 00 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | structure activity relationships |
| 653 00 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | laboratory animals |
| 653 00 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | human diseases |
| 653 00 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | acetyl-CoA carboxylase |
| 653 00 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | nanomaterials |
| 653 00 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | mycoses |
| 653 00 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | antibacterial agents |
| 653 00 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | bacterial infections |
| 653 00 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | fungicides |
| 653 00 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | drug susceptibility |
| 653 00 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | resistance mechanisms |
| 653 00 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | fungi |
| 653 00 - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | lysostaphin |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tegos, A. |
| Relator code | edt |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mylonakis, E. |
| Relator code | edt |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Display text | Printed edition: |
| International Standard Book Number | 9781845939434 |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
| Uniform title | Advances in Molecular and Cellular Microbiology |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://www.cabidigitallibrary.org/action/showBook?doi=10.1079%2F9781845939434.0000">https://www.cabidigitallibrary.org/action/showBook?doi=10.1079%2F9781845939434.0000</a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Koha item type | E-BOOKS |
No items available.